R&D teams manually cross-checked trial data. AI now summarizes hour-long calls in 30 seconds and synthesizes analyst consensus instantly.
A biotechnology company operating in Europe and the U.S. focused on oncology and immunology, recently rebuilding its R&D portfolio following a €50 million business unit divestment.
Competitive intelligence gathering was manual and ad-hoc, requiring teams to manage multiple subscriptions and track clinical trials by hand....
“The breadth of broker coverage is tremendous, and there isn’t really anyone else that comes close.”
Biotechnology company developing medicines for immunology and oncology.
AI-powered market intelligence and search platform for business professionals.
Related implementations across industries and use cases
Manual data stitching bottlenecked insights. A unified AI hub now saves analysts 8 hours weekly, cutting research time to minutes.
Tracking trends took 24 hours of manual sifting. AI now aggregates insights instantly, eliminating the need for external consultants.
Manually analyzing hundreds of transcripts took 21 days. A GenAI chatbot now surfaces insights in just two.
Silos forced teams to manually chase data. Now, AI agents identify adverse events in seconds, eliminating weeks of cross-referencing.
Attorneys juggled fragmented tools to search 50,000 cases. An AI orchestrator now routes queries to sub-agents in a single chat.
Rigid queries across scattered systems missed intel. Natural language search now captures synonyms and unifies sources automatically.
Scattered manual research slowed high-stakes answers. GenAI now cuts analysis from weeks to minutes for 13,000 employees.